CNBC |
Alexion Names Paul Clancy Chief Financial Officer
Business Wire (press release) BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Paul J. Clancy, a seasoned financial executive with 30 years of experience, will join the company on July 10, 2017 and will assume the role of Chief Financial Officer (CFO … Biogen (BIIB) CFO to Leave to Join Another Biopharmaceutical …StreetInsider.com Alexion hires Biogen executive to serve as its CFOMarketWatch Alexion taps Biogen veteran Paul Clancy as CFONasdaq TheStreet.com all 10 news articles » |
June 14, 2017 at 03:31AM
from
No comments:
Post a Comment